Transcription activation by catabolite activator protein (CAP)
- 作者Steve Busby; Richard H Ebright
- 卷第293卷
- 期第2期
- 印刷ISSN0022-2836
- 电子ISSN1089-8638
- 文件大小504.70KB
- 发表时间1999
- DOI10.1006/jmbi.1999.3161
Elaborate Manifold of Short Hydrogen Bond Arrays Mediating Binding of Active Site-directed Serine Protease InhibitorsBradley A. Katz; Kyle Elrod; Erik Verner; Richard L. Mackman; Christine Luong; William D. Shrader; Martin Sendzik; Jeffrey R. Spencer; Paul A. Sprengeler; Aleks Kolesnikov; Vincent W.-F. Tai; Hon C. Hui; J. Guy Breitenbucher; Darin Allen; James W. Janc · 2003
Dissecting and Designing Inhibitor Selectivity Determinants at the S1 Site Using an Artificial Ala190 Protease (Ala190 uPA)Bradley A. Katz; Christine Luong; Joseph D. Ho; John R. Somoza; Erik Gjerstad; Jie Tang; Steven R. Williams; Erik Verner; Richard L. Mackman; Wendy B. Young; Paul A. Sprengeler; Hedy Chan; Kyle Mortara; James W. Janc; Mary E. McGrath · 2004
2-(2-Hydroxy-3-alkoxyphenyl)-1H-benzimidazole-5-carboxamidine derivatives as potent and selective urokinase-type plasminogen activator inhibitorsRichard L. Mackman; Hon C. Hui; J.Guy Breitenbucher; Bradley A. Katz; Christine Luong; Arnold Martelli; Danny McGee; Kesavan Radika; Martin Sendzik; Jeffrey R. Spencer; Paul A. Sprengeler; James Tario; Erik Verner; Jing Wang · 2002
Exploiting Subsite S1 of Trypsin-Like Serine Proteases for Selectivity: Potent and Selective Inhibitors of Urokinase-Type Plasminogen ActivatorMackman, Richard L.; Katz, Bradley A.; Breitenbucher, J. Guy; Hui, Hon C.; Verner, Erik; Luong, Christine; Liu, Liang; Sprengeler, Paul A. · Journal of Medicinal Chemistry · 2001